| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
6e-05 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |